Drug Profile
QP CP1
Alternative Names: QP-CP1Latest Information Update: 28 Jan 2024
Price :
$50
*
At a glance
- Originator Quark Pharmaceuticals
- Class Small interfering RNA
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Myocardial infarction
Most Recent Events
- 28 Jan 2024 No recent reports of development identified for research development in Myocardial-infarction in USA (Parenteral)
- 30 Jan 2020 Early research for Myocardial infarction is ongoing USA
- 17 Nov 2015 Early research in Myocardial infarction in USA (Parenteral)